Oncologists envision a move towards using data to become a learning health system, which is aided by the changing landscape emphasizing quality and value, explained Bobby Green, MD, MSCE, senior vice president of clinical oncology at Flatiron Health.
Oncologists envision a move towards using data to become a learning health system, which is aided by the changing landscape emphasizing quality and value, explained Bobby Green, MD, MSCE, senior vice president of clinical oncology at Flatiron Health.
Transcript (slightly modified)
How can learnings from big data be better incorporated in everyday care?
That question really gets at the point of what is a learning healthcare system. We’re very, very early here, but I think the vision which is shared among a lot of people in this field is that you go from measurement to making interventions to measuring the outcomes that come from those interventions, and then taking those data, understanding what the outcomes of your interventions are, and then feeding that back into the system, so you can learn from what you’ve done before and adjust the interventions that you’re making to further improve care.
I think we’re very, very early, but all of the work that’s being done now ultimately leads to that idea of a learning healthcare system, which was advocated several years ago by the Institute of Medicine. A lot of the work being done now, you can view as being steps towards that ultimate goal.
How has the push toward payment reform advanced the use of data analytics to improve care?
There is no question that the changing landscape is driving a lot of this, and I think the perfect example of that is the Oncology Care Model. Both from a theoretical perspective, now people are starting to think about quality and cost in ways that they weren’t before, but also at a very practical level. CMS is now giving pretty rich claims data to a lot of practices that have never seen data like this before. It’s really opening up a whole new opportunity to take those data, analyze it, understand it, and use it to help practices transform how they’re taking care of patients and to become proficient in the process of care delivery.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More